HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
rhGAD65
Description
rhGAD65 (recombinant human glutamic acid decarboxylase) is a vaccine being developed to treat insulin dependent type 1 diabetes.
Company not known
Diamyd
